Načítá se...
A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice
Human papilliomavirus (HPV) oncogene E7, essential for the transformation and maintenance of the malignancy of cervical cancer cells, represents an ideal tumor-specific antigen for vaccine development. However, due to the poor immunogenicity of E7 protein, an effective therapeutic E7 vaccine is stil...
Uloženo v:
Vydáno v: | Oncoimmunology |
---|---|
Hlavní autoři: | , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Taylor & Francis
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4938372/ https://ncbi.nlm.nih.gov/pubmed/27471615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1147641 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|